Beta‐carotene vs placebo
Progression to late AMD (neovascular AMD, geographic atrophy or both) · general population
Beta‐carotene showed no clear difference in late AMD (either neovascular AMD or geographic atrophy or both) compared with placebo (moderate certainty).
1 finding from 1 review
- Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration 2017 · Cochrane Headline outcomes onlyRR 0.9 [0.65, 1.24]2 studies · 22083 participantsModerate